SCHEMBL13520175

SCHEMBL13520175

CCCCCC(C)CCCN

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 8/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
ALDH1A1 P00352 1/20 0.52
TSHR P16473 1/20 0.52
EPHX1 P07099 1/20 0.52
OPRM1 P35372 1/20 0.52
ACE2 Q9BYF1 1/20 0.48
SPHK1 Q9NYA1 1/20 0.48
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.41
FDPS P14324 1/20 0.39
GNAI3 P08754 1/20 0.39
GNAO1 P09471 1/20 0.39
GNAI1 P63096 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24835048 0.97 DNM1 (0.57) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL3626056 0.97 DNM1 (0.57) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL3614673 0.97 DNM1 (0.57) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL3625787 0.97 DNM1 (0.57) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL3617680 0.97 DNM1 (0.57) DNM1MEN1KMT2AALDH1A1TSHR
Hydrochloric Acid SCHEMBL28512813 0.95 DNM1 (0.59) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL19708567 0.95 ACE2 (0.55) DNM1MEN1KMT2AALDH1A1TSHR
Hydrochloric Acid SCHEMBL8579435 0.95 DNM1 (0.59) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL3626321 0.95 DNM1 (0.60) DNM1MEN1KMT2AALDH1A1TSHR
SCHEMBL3620472 0.92 DNM1 (0.65) DNM1MEN1KMT2AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12246000-B2 Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides VILNIUS UNIVERSITY (LT) 2025-03-11 US disclosed
US-20240000736-A1 INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES VILNIUS UNIVERSITY (LT) 2024-01-04 US disclosed
EP-4299062-A1 INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES Vilnius University (LT) 2024-01-03 EP disclosed
EP-3294333-B1 CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES BIONTECH CELL&GENE THERAPIES GMBH (DE) 2020-09-02 EP disclosed
US-9718947-B2 Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof GNOSIS S.P.A. (IT) 2017-08-01 US disclosed
US-20100021119-A1 OPTICAL WAVEGUIDE FILM, METHOD OF PRODUCING THE SAME, AND OPTICAL TRANSMITTER AND RECEIVER MODULE FUJI XEROX CO., LTD. (JP) 2010-01-28 US disclosed
US-7348135-B2 Assay for detecting changes in mitochondrial membrane permeability and method of using same UNIVERSITY OF MARYLAND (US) 2008-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240000736-A1 INHIBITION OF PROTEIN AMYLOID AGGREGATION USING FLUORINATED BENZENESULFONAMIDES APP, APBA1, IAPP DNM1 1983/4885MEN1 1754/4885KMT2A 3425/4885
US-12246000-B2 Inhibition of protein amyloid aggregation using fluorinated benzenesulfonamides APP, APBA1, IAPP DNM1 1983/4885MEN1 1754/4885KMT2A 3425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.